Literature DB >> 32540958

Hydroxychloroquine for covid-19: the end of the line?

Elisabeth Mahase1.   

Abstract

Entities:  

Year:  2020        PMID： 32540958     DOI： 10.1136/bmj.m2378

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  15 in total

Review 1.  COVID-19 Treatment Guidelines: Do They Really Reflect Best Medical Practices to Manage the Pandemic?

Authors:  Feras Jirjees; Ali K Saad; Zahraa Al Hano; Taher Hatahet; Hala Al Obaidi; Yahya H Dallal Bashi
Journal:  Infect Dis Rep       Date:  2021-04-01

Review 2.  Might proton pump or sodium-hydrogen exchanger inhibitors be of value to ameliorate SARs-CoV-2 pathophysiology?

Authors:  Kirk P Conrad
Journal:  Physiol Rep       Date:  2021-01

3.  A two-arm, randomized, controlled, multi-centric, open-label phase-2 study to evaluate the efficacy and safety of Itolizumab in moderate to severe ARDS patients due to COVID-19.

Authors:  Suresh Kumar; Rosemarie De Souza; Milind Nadkar; Randeep Guleria; Anjan Trikha; Shashank R Joshi; Subramanian Loganathan; Sivakumar Vaidyanathan; Ashwani Marwah; Sandeep N Athalye
Journal:  Expert Opin Biol Ther       Date:  2021-04-09       Impact factor: 4.388

4.  Reply to Wolowich and Kwon.

Authors:  Miao Zhang; Xueting Yao; Cheng Cui; Xu Liu; Haiyan Li; Dongyang Liu
Journal:  Clin Infect Dis       Date:  2021-05-04       Impact factor: 9.079

5.  Dual inhibition of COVID-19 spike glycoprotein and main protease 3CLpro by Withanone from Withania somnifera.

Authors:  Vishal Shivalingappa Patil; Vrushabh B Hupparage; Ajay P Malgi; Sanjay H Deshpande; Sathgowda A Patil; Shamanand P Mallapur
Journal:  Chin Herb Med       Date:  2021-06-24

6.  Mild and moderate COVID-19 disease does not affect hearing function permanently: a cross-sectional study ınvolving young and middle-aged healthcare givers.

Authors:  Kerem Kökoğlu; Nezaket Tektaş; Fidan Elif Baktir-Okcesiz; Mehmet İlhan Şahin
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-06-29       Impact factor: 2.503

7.  Antibiotic resistance during and beyond COVID-19.

Authors:  David M Livermore
Journal:  JAC Antimicrob Resist       Date:  2021-06-15

8.  Investigating the Prevalence of Reactive Online Searching in the COVID-19 Pandemic: Infoveillance Study.

Authors:  Rafael A Badell-Grau; Jordan Patrick Cuff; Brendan P Kelly; Helen Waller-Evans; Emyr Lloyd-Evans
Journal:  J Med Internet Res       Date:  2020-10-27       Impact factor: 5.428

Review 9.  Therapeutic strategies against COVID-19.

Authors:  Susanna Esposito; Margherita Gnocchi; Martina Gagliardi; Paola Affanni; Licia Veronesi; Maria Eugenia Colucci; Cosimo Neglia; Alberto Argentiero; Nicola Principi
Journal:  Acta Biomed       Date:  2020-09-07

Review 10.  Azithromycin and COVID-19: Prompt early use at first signs of this infection in adults and children, an approach worthy of consideration.

Authors:  Robert A Schwartz; Robert M Suskind
Journal:  Dermatol Ther       Date:  2020-07-12       Impact factor: 3.858
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.